AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 525213: Chloromethyl 5-chloro-octanoate

Chemical compound data from PubChem database. IUPAC Name: chloromethyl 5-chlorooctanoate. Molecular Formula: C9H16Cl2O2. Molecular Weight: 227.12. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Fluctuations of inspired concentrations of nitric oxide and nitrogen
		  dioxide during mechanical ventilation

Background:
          Nitric oxide (NO) is a very reactive agent with potentially toxic
				oxidation products such as nitrogen dioxide (NO2). Therefore, during
				NO inhalation a constant inspired concentration and accurate measurement of NO
				and NO2 concentrations are essential. The objective of this study
				was to test the NO concentrations at various positions along the inspiratory
				limb of the breathing circuit using a recently developed system to administer
				NO in phase with inspiratory flow during mechanical ventilation (Servo 300
				NO-A, Siemens, Sweden). Furthermore, we tested whether an active heating system
				would interfere with inspired NO concentrations.
        
        
          Results:
          A sharp decline in the NO concentration was found between the
				respirator's inspiratory outlet and more distal points along the inspiratory
				limb of the circuit. This finding was most evident when an active heating
				system was mounted between those points.
        
        
          Conclusions:
          The concentrations of NO and NO2 should be measured as
				near to the patient as possible, as significant fluctuations of these
				concentrations might be found along the inspiratory limb of the respiratory
				circuit especially when an active heating system is used.
The mouse anterior chamber angle and trabecular meshwork develop 
without cell death

Background
          The iridocorneal angle forms in the mammalian eye from undifferentiated 
mesenchyme between the root of the iris and cornea. A major component is the 
trabecular meshwork, consisting of extracellular matrix organized into a 
network of beams, covered in trabecular endothelial cells. Between the beams, 
channels lead to Schlemm's canal for the drainage of aqueous humor from the eye 
into the blood stream. Abnormal development of the iridocorneal angle that 
interferes with ocular fluid drainage can lead to glaucoma in humans. Little is 
known about the precise mechanisms underlying angle development. There are two 
main hypotheses. The first proposes that morphogenesis involves mainly cell 
differentiation, matrix deposition and assembly of the originally continuous 
mesenchymal mass into beams, channels and Schlemm's canal. The second, based 
primarily on rat studies, proposes that cell death and macrophages play an 
important role in forming channels and beams. Mice provide a potentially useful 
model to understand the origin and development of angle structures and how 
defective development leads to glaucoma. Few studies have assessed the normal 
structure and development of the mouse angle. We used light and electron 
microscopy and a cell death assay to define the sequence of events underlying 
formation of the angle structures in mice.
        
        
          Results
          The mouse angle structures and developmental sequence are similar to those 
in humans. Cell death was not detectable during the period of trabecular 
channel and beam formation.
        
        
          Conclusions
          These results support morphogenic mechanisms involving organization of 
cellular and extracellular matrix components without cell death or atrophy.
Patent AT-E401203-T1: [Translated] CARRIER FOR FLAT PLATE PLATE AND PRE-SENSITIZED PRINTING PLATE

Disclosed is a support for a lithographic printing plate which, when measured over a 400 µm x 400 µm surface region thereon using a three-dimensional non-contact roughness tester, has at most 5.0 convex portions of a height from centerline of at least 0.70 µm and an equivalent circle diameter of at least 20 µm, and has at least 800 concave portions of a depth from centerline of at least 0.50 µm and an equivalent circle diameter of at least 2.0 µm. Presensitized plates which are obtainable by using the support for a lithographic printing plate according to the present invention have an excellent scumming resistance and an extremely long press life.
Compound 528321: 2-Methoxy-3-pentylpyrazine

Chemical compound data from PubChem database. IUPAC Name: 2-methoxy-3-pentylpyrazine. Molecular Formula: C10H16N2O. Molecular Weight: 180.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2019-2020 NSDUH State-Specific Tables

State estimates for these years are no longer available due to methodological concerns with combining 2019 and 2020 data. We apologize for any inconvenience or confusion this may causeBecause of the COVID-19 pandemic, most respondents answered the survey via the web in Quarter 4 of 2020, even though all responses in Quarter 1 were from in-person interviews. It is known that people may respond to the survey differently while taking it online, thus introducing what is called a mode effect.When the state estimates were released, it was assumed that the mode effect was similar for different groups of people. However, later analyses have shown that this assumption should not be made. Because of these analyses, along with concerns about the rapid societal changes in 2020, it was determined that averages across the two years could be misleading.For more detail on this decision, see the 2019-2020state data page.
Patent AT-E399900-T1: [Translated] METHOD FOR PRODUCING PULP USING A MIXTURE OF ACETIC ACID AND FORMIC ACID AS COOKING CHEMICALS

A process based on formic acid cooking for producing pulp from herbaceous plants and deciduous trees by using acetic acid as an additional cooking chemical. The obtained pulp can be used in fine paper and board production as short-fibered material, for instance. The invention also relates to a process for adjusting the hemicellulose content of the pulp in connection with the formic acid cooking by using acetic acid as an additional cooking chemical.
Reviewer Brief — Calculating 15 Out of 22 Months for the Purpose of Meeting Termination of Parental Rights Requirement

This reviewer brief provides instructions on how to calculate, for the purposes of the CFSR, the “15 out of the 22 most recent months” provision for determining whether to file a termination of parental rights (TPR) for children in foster care. The TPR requirement, as outlined in the Social Security Act at § 475(5)(E), requires states to make timely decisions regarding permanency for children in foster care by having states and applicable tribes file a TPR petition when a child has been in foster care for at least 15 of the most recent 22 months and an exception or a compelling reason does not apply.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E400601-T1: [Translated] METHOD FOR PRODUCING INITIATOR SLURRIES FROM METAL CYANIDE POLYOLS

Metal cyanide catalyst dispersions in initiator compounds are prepared by precipitating the catalyst in an inert organic compound, mixing the resulting slurry with the initiator and stripping off the inert organic compound. Using this method, an active alkylene oxide polymerization catalyst is prepared. It is not necessary to use a separate organic complexing agent in the preparation.
A systematic review of the quality of homeopathic clinical trials

Background
          While a number of reviews of homeopathic clinical trials have been done, all have used methods dependent on allopathic diagnostic classifications foreign to homeopathic practice. In addition, no review has used established and validated quality criteria allowing direct comparison of the allopathic and homeopathic literature.
        
        
          Methods
          In a systematic review, we compared the quality of clinical-trial research in homeopathy to a sample of research on conventional therapies using a validated and system-neutral approach. All clinical trials on homeopathic treatments with parallel treatment groups published between 1945–1995 in English were selected. All were evaluated with an established set of 33 validity criteria previously validated on a broad range of health interventions across differing medical systems. Criteria covered statistical conclusion, internal, construct and external validity. Reliability of criteria application is greater than 0.95.
        
        
          Results
          59 studies met the inclusion criteria. Of these, 79% were from peer-reviewed journals, 29% used a placebo control, 51% used random assignment, and 86% failed to consider potentially confounding variables. The main validity problems were in measurement where 96% did not report the proportion of subjects screened, and 64% did not report attrition rate. 17% of subjects dropped out in studies where this was reported. There was practically no replication of or overlap in the conditions studied and most studies were relatively small and done at a single-site. Compared to research on conventional therapies the overall quality of studies in homeopathy was worse and only slightly improved in more recent years.
        
        
          Conclusions
          Clinical homeopathic research is clearly in its infancy with most studies using poor sampling and measurement techniques, few subjects, single sites and no replication. Many of these problems are correctable even within a "holistic" paradigm given sufficient research expertise, support and methods.
Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings

This report presents results from the 2010 National Survey on Drug Use and Health (NSDUH). The report includes national estimates of rates of initiation and use of illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives), alcohol, and tobacco products and rates of driving under the influence of drugs or alcohol. The report also covers substance use treatment need/receipt and youth risk and prevention measures. Results are provided for age group, gender, pregnancy status, race/ethnicity, education level, employment status, geographic area, parole/probation status. Comparisons are made between 2010 and 2002 to 2009.
Compound 528146: 5-Sec-butyl-2-ethylthio-3-methylpyrazine

Chemical compound data from PubChem database. IUPAC Name: 5-butan-2-yl-2-ethylsulfanyl-3-methylpyrazine. Molecular Formula: C11H18N2S. Molecular Weight: 210.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530632: Valeric acid, 2-methyloct-5-yn-4-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2-methyloct-5-yn-4-yl pentanoate. Molecular Formula: C14H24O2. Molecular Weight: 224.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525451: 3-Methyl-4,6-dithianonane

Chemical compound data from PubChem database. IUPAC Name: 2-(propylsulfanylmethylsulfanyl)butane. Molecular Formula: C8H18S2. Molecular Weight: 178.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527234: (3S,3aS,6R,8aS)-3,8,8-Trimethyl-7-methyleneoctahydro-1H-3a,6-methanoazulene

Chemical compound data from PubChem database. IUPAC Name: 2,6,6-trimethyl-7-methylidenetricyclo[6.2.1.01,5]undecane. Molecular Formula: C15H24. Molecular Weight: 204.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530122: 4-Pyrimidinamine, 5-methyl-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-

Chemical compound data from PubChem database. IUPAC Name: 5-methyl-N-trimethylsilyl-2-trimethylsilyloxypyrimidin-4-amine. Molecular Formula: C11H23N3OSi2. Molecular Weight: 269.49. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Publications Using SAMHSA Data2012 Uniform Reporting  System (URS) Tables for Minnesota

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
NNDSS - Table II. Hepatitis (viral, acute, by type) C

NNDSS - Table II. Hepatitis (viral, acute, by type) C - 2018. In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states or territory.

Note:

This table contains provisional cases of selected national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up.  Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html.
 
Footnotes:

C.N.M.I.: Commonwealth of Northern Mariana Islands. 
U: Unavailable. —: No reported cases. N: Not reportable. NA:  Not Available.  NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. 

* Case counts for reporting years 2017 and 2018 are provisional and subject to change. Data for years 2013 through 2016 are finalized. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf.  

† For acute Hepatitis C, only confirmed cases were verified.
2022 Uniform Reporting System (URS) Table For Northern Mariana Islands

This is the 2022 Uniform Reporting System (URS) Output Tables for Northern Mariana Islands. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence-based practices, and utilization measures providing an overview of state mental health delivery systems.
Secondary Traumatic Stress

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 526914: 2-Pentoxyethyl trifluoroacetate

Chemical compound data from PubChem database. IUPAC Name: 2-pentoxyethyl 2,2,2-trifluoroacetate. Molecular Formula: C9H15F3O3. Molecular Weight: 228.21. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Advances in Targeted Therapies III, Nassau, Bahamas, 27 April-1 May 2001

This conference was the third in a series focusing on developments in the therapy of rheumatoid arthritis (RA) and other rheumatic conditions with biologicals; in many ways, it was perhaps the best one so far. One strength of the meeting was the mix of scientists from academia and from industry, and of workers in basic science as well as clinical investigators. The risks of inhibition of tumor necrosis factor (TNF) were covered in depth for the first time. A number of putative and actual new targets were presented. An updated consensus document on the use of TNF inhibitors will appear in the near future in the Annals of Rheumatic Diseases, authored by Dan Furst et al.
State-Level Vaccine Mandates - Currently in Effect

This dataset contains state and territorial vaccine mandates currently in effect as of ____ that require the group listed to be fully vaccinated. State and territorial laws are collected from publicly available government websites and cataloged and coded using HHS Protect by one coder with one or more additional coders conducting quality assurance.
Data were collected to determine when certain groups were subject to vaccine mandates. Data can be used to determine the status of state-issued vaccine requirements for certain groups as of the date of last update. 
These data are derived from publicly available state and territorial laws and official policy documents found by CDC’s Mitigation Policy Analysis Unit, and CDC’s Center for State, Tribal, Local, and Territorial Support, Public Health Law Program from July 26, 2021 through _____. These data will be updated as new laws are collected. Any orders not available through publicly accessible websites are not included in this dataset. Recommendations not included in a law are not included in these data. Effective and expiration dates were coded using only the date provided in the law. These data do not necessarily represent the official position of the Centers for Disease Control and Prevention.
The Permanency Innovations Initiative: An Example of Building Evidence in Child Welfare

With growing interest in using evidence-based programs across the Federal Government, this video emphasizes how the PII approach exemplifies the four criteria of evidence-based policymaking. PII has increased the body of evidence, developed a step-wise process for building evidence, and contributed to creating a culture of evidence in the child welfare field.

Metadata-only record linking to the original dataset. Open original dataset below.
Medi-Cal Managed Care Capitation Rates – County Organized Health Systems (COHS) Model

This dataset displays reimbursement rates paid to Medi-Cal Managed Care health plans in the COHS model, by State Fiscal Year. The COHS serve beneficiaries in 22 counties. In the COHS model counties, the Department of Health Care Services (DHCS) contracts with a health plan created by the county Board of Supervisors.  In a COHS county, all Medi-Cal members are enrolled in the same managed care health plan.
Patent AT-E400499-T1: [Translated] AIR CARGO NETWORK

The invention relates to an air cargo net; that is to a net that is applied to restrain cargo that has been placed on a pallet and to prevent shifting of the cargo in an aircraft during transport, which net comprises a plurality of ropes made from polymer fibers, which ropes are joined at intervals to form meshes, the net having a central part and a plurality of lobes projecting there from, the peripheral meshes of each lobe being formed by a border rope, each border rope having a plurality of attachment fittings that are connected to the border rope by replaceable connecting ropes. The invention also relates to a method of connecting an attachment fitting to a rope of an air cargo net with an auxiliary connecting rope.
Compound 529772: Pholedrine, N-TFA-O-TMS

Chemical compound data from PubChem database. IUPAC Name: 2,2,2-trifluoro-N-methyl-N-[1-(4-trimethylsilyloxyphenyl)propan-2-yl]acetamide. Molecular Formula: C15H22F3NO2Si. Molecular Weight: 333.42. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529815: Butanal, 3-methyl, 2,4,6-trichlorophenyl hydrazone, #1

Chemical compound data from PubChem database. IUPAC Name: 2,4,6-trichloro-N-(3-methylbutylideneamino)aniline. Molecular Formula: C11H13Cl3N2. Molecular Weight: 279.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401104-T1: [Translated] SAFETY SYSTEM FOR AN ELECTRICALLY POWERED MEDICAL ADMINISTRATION SYSTEM AND COMPUTER READABLE MEDIUM

This invention relates to a safety system for an electrically driven medical delivery device for delivering a dose of medication, wherein the safety system is configured for preventing delivery of an erroneous dose of the medicament and comprising detector means for registering mechanical movement, the system comprising at least two detector means (10, 11) for detecting a mechanical parameter and for emitting signals to control circuits (14, 15) configured for controlling the power supply to driving means (12) for the delivery device. Further, this invention relates to a computer-readable medium comprising a program for controlling a delivery device etc. This allows providing a system that works very quickly, accurately and reliable as to preventing an erroneous dose of medication.
National Survey of Substance Abuse Treatment Services (N-SSATS): 2013 Data on Substance Abuse Treatment Facilities

This report presents results from the 2013 National Survey of Substance Abuse Treatment Services (N-SSATS), an annual census of facilities providing substance abuse treatment. Conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), the N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 states, the District of Columbia, and other U.S. jurisdictions
Compound 528733: m-Octopamine, DTFMB-TBDMS

Chemical compound data from PubChem database. IUPAC Name: N-[2-[tert-butyl(dimethyl)silyl]oxy-2-[3-[tert-butyl(dimethyl)silyl]oxyphenyl]ethyl]-3,5-bis(trifluoromethyl)benzamide. Molecular Formula: C29H41F6NO3Si2. Molecular Weight: 621.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528320: Pyrazine, 3-methoxy-2-octyl

Chemical compound data from PubChem database. IUPAC Name: 2-methoxy-3-octylpyrazine. Molecular Formula: C13H22N2O. Molecular Weight: 222.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.